InvestorsObserver
×
News Home

TapImmune Inc. common stock (MRKR) Stock Has Fallen -22.50% This Week: Buy, Hold, or Sell?

Friday, January 21, 2022 02:46 PM | InvestorsObserver Analysts

Mentioned in this article

TapImmune Inc. common stock (MRKR) Stock Has Fallen -22.50% This Week: Buy, Hold, or Sell?

TapImmune Inc. common stock (MRKR) stock is lower by -69.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MRKR stock a score of 27 out of a possible 100. That rank is influenced by a short-term technical score of 2. MRKR's rank also includes a long-term technical score of 9. The fundamental score for MRKR is 70. In addition to the average rating from Wall Street analysts, MRKR stock has a mean target price of $6.38. This means analysts expect the stock to climb 928.23% over the next 12 months.

Overall Score - 27
MRKR has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on MRKR!

What's Happening with MRKR Stock Today

TapImmune Inc. common stock (MRKR) stock is lower by -17.35% while the S&P 500 is lower by -1.12% as of 2:45 PM on Friday, Jan 21. MRKR is lower by -$0.13 from the previous closing price of $0.75 on volume of 1,708,315 shares. Over the past year the S&P 500 has risen 15.04% while MRKR is lower by -69.46%. MRKR lost -$0.61 per share in the over the last 12 months. Click Here to get the full Stock Report for TapImmune Inc. common stock stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App